These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37118924)

  • 61. Tobacco Quitline Callers Who Use Cannabis and Their Likelihood of Quitting Cigarette Smoking.
    Zhu SH; Tedeschi GJ; Li S; Wang J; Aughinbaugh E; Pratt AS; Zhuang YL
    Am J Prev Med; 2024 Aug; 67(2):241-248. PubMed ID: 38484902
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy.
    An LC; Schillo BA; Kavanaugh AM; Lachter RB; Luxenberg MG; Wendling AH; Joseph AM
    Tob Control; 2006 Aug; 15(4):286-93. PubMed ID: 16885577
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Safety Net Tobacco Use Cessation Resource: Quitline Service Usage, 2019.
    Tetlow SM; Zhang L; Borowiecki M; Kim Y; Gentzke AS; Wang TW; Cornelius ME; Hawkins NA
    Prev Chronic Dis; 2023 Sep; 20():E84. PubMed ID: 37769250
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of Local Flavored Tobacco Sales Restrictions on Policy-Related Attitudes and Tobacco Product Access.
    Feld AL; Rogers T; Gaber J; Pikowski J; Farrelly MC; Henriksen L; Johnson TO; Halpern-Felsher B; Andersen-Rodgers E; Zhang X
    Health Educ Behav; 2022 Jun; 49(3):468-477. PubMed ID: 34399591
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Flavoring Patterns of Exclusive and Dual-Use of Cigarettes and E-Cigarettes Among US Adults: Results from the TUS-CPS 2018-2019.
    Zavala-Arciniega L; Hirschtick JL; Meza R; Fleischer NL
    Am J Health Promot; 2022 Nov; 36(8):1339-1345. PubMed ID: 35499236
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Flavored Tobacco Use Among U.S. Adults by Age Group: 2013-2014.
    Dai H; Hao J
    Subst Use Misuse; 2019; 54(2):315-323. PubMed ID: 30380969
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Behavioural intentions in response to a potential menthol cigarette sales ban: a survey examining smokers in Washington, DC public housing.
    Dearfield CT; Horn K; Crandell I; Bernat DH
    BMJ Open; 2022 Jul; 12(7):e059821. PubMed ID: 35831050
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Should menthol e-cigarettes be banned? Reaction of adult smokers and users of e-cigarettes to hypothetical bans.
    Yang Y; Lindblom EN; Ward KD; Salloum RG
    Tob Control; 2024 Mar; 33(e1):e125-e127. PubMed ID: 36446577
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Direct-to-Member Household or Targeted Mailings: Incentivizing Medicaid Calls for Quitline Services.
    Hood-Medland EA; Dove MS; Stewart SL; Cummins SE; Kirby C; Vela C; Kohatsu ND; Tong EK
    Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S178-S185. PubMed ID: 30454672
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changes in Sales of Vaping Products and Cigarettes Associated With the New York State Flavored Vaping Product Sales Restriction.
    Brown EM; Rogers T; Spinks JG; Gammon D; Nonnemaker J; Farrelly MC
    Nicotine Tob Res; 2024 Jan; 26(2):135-141. PubMed ID: 37659102
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Medicaid Incentives for Preventing Chronic Disease: Effects of Financial Incentives for Smoking Cessation.
    Witman A; Acquah J; Alva M; Hoerger T; Romaire M
    Health Serv Res; 2018 Dec; 53(6):5016-5034. PubMed ID: 29896800
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Offering free NRT through a tobacco quitline: impact on utilisation and quit rates.
    Tinkelman D; Wilson SM; Willett J; Sweeney CT
    Tob Control; 2007 Dec; 16 Suppl 1(Suppl 1):i42-6. PubMed ID: 18048631
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Self-Reported Quit Aids and Assistance Used By Smokers At Their Most Recent Quit Attempt: Findings from the 2020 International Tobacco Control Four Country Smoking and Vaping Survey.
    Gravely S; Cummings KM; Hammond D; Borland R; McNeill A; East KA; Loewen R; Martin N; Yong HH; Li L; Liber A; Levy DT; Quah ACK; Ouimet J; Hitchman SC; Thompson ME; Boudreau C; Fong GT
    Nicotine Tob Res; 2021 Aug; 23(10):1699-1707. PubMed ID: 33837435
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Substitution of flavored cigarillos with menthol cigarettes among young adults in the U.S.
    Abeyesundere N; Osborn CC; Pike Moore S; Suratkal JP; Kaur M; Otieno C; Quisenberry AJ; Klein EG; Trapl ES
    Drug Alcohol Depend; 2022 Oct; 239():109603. PubMed ID: 35987085
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ENDS Flavor Preference by Menthol Cigarette Smoking Status among US Adults, 2018-2019.
    Rostron BL; Chang JT; Chang CM; Jackson RA; Ambrose BK
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33396201
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Perceptions of the US National Tobacco Quitline Among Adolescents and Adults: A Qualitative Study, 2012-2013.
    Waters EA; McQueen A; Caburnay CA; Boyum S; Sanders Thompson VL; Kaphingst KA; Kreuter MW
    Prev Chronic Dis; 2015 Aug; 12():E131. PubMed ID: 26292062
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study.
    Lent AB; O'Connor PA; Reikowsky RC; Nair US; Bell ML
    BMC Public Health; 2018 Aug; 18(1):1001. PubMed ID: 30097065
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intermediate cessation outcomes among quitline callers during a national tobacco education campaign.
    Zhang L; Vickerman K; Malarcher A; Mowery P
    Nicotine Tob Res; 2014 Nov; 16(11):1478-86. PubMed ID: 25006045
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Outcomes and cost-effectiveness of two nicotine replacement treatment delivery models for a tobacco quitline.
    Saul JE; Lien R; Schillo B; Kavanaugh A; Wendling A; Luxenberg M; Greenseid L; An LC
    Int J Environ Res Public Health; 2011 May; 8(5):1547-59. PubMed ID: 21655136
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.